These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 33063569)

  • 1. Incorporation of the LETd-weighted biological dose in the evaluation of breast intensity-modulated proton therapy plans.
    Liu C; Zheng D; Bradley JA; Mailhot Vega RB; Zhang Y; Indelicato DJ; Mendenhall N; Liang X
    Acta Oncol; 2021 Feb; 60(2):252-259. PubMed ID: 33063569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interlaced proton grid therapy - Linear energy transfer and relative biological effectiveness distributions.
    Henry T; Ödén J
    Phys Med; 2018 Dec; 56():81-89. PubMed ID: 30473384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spatial correlation of linear energy transfer and relative biological effectiveness with suspected treatment-related toxicities following proton therapy for intracranial tumors.
    Ödén J; Toma-Dasu I; Witt Nyström P; Traneus E; Dasu A
    Med Phys; 2020 Feb; 47(2):342-351. PubMed ID: 31705671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of dose-averaged linear energy transfer (LET
    Rana S; Traneus E; Jackson M; Tran L; Rosenfeld AB
    Med Phys; 2022 May; 49(5):3444-3456. PubMed ID: 35194809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RBE-weighted dose and its impact on the risk of acute coronary event for breast cancer patients treated with intensity modulated proton therapy.
    Liu C; Bradley JA; Zheng D; Vega RBM; Beltran CJ; Mendenhall N; Liang X
    J Appl Clin Med Phys; 2022 Apr; 23(4):e13527. PubMed ID: 35060317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Introducing Proton Track-End Objectives in Intensity Modulated Proton Therapy Optimization to Reduce Linear Energy Transfer and Relative Biological Effectiveness in Critical Structures.
    Traneus E; Ödén J
    Int J Radiat Oncol Biol Phys; 2019 Mar; 103(3):747-757. PubMed ID: 30395906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantifying the Dosimetric Impact of Proton Range Uncertainties on RBE-Weighted Dose Distributions in Intensity-Modulated Proton Therapy for Bilateral Head and Neck Cancer.
    Rana S; Manthala Padannayil N; Tran L; Rosenfeld AB; Saeed H; Kasper M
    Curr Oncol; 2024 Jun; 31(7):3690-3697. PubMed ID: 39057144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of range uncertainty on clinical distributions of linear energy transfer and biological effectiveness in proton therapy.
    Hahn C; Eulitz J; Peters N; Wohlfahrt P; Enghardt W; Richter C; Lühr A
    Med Phys; 2020 Dec; 47(12):6151-6162. PubMed ID: 33118161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of linear energy transfer computed in a Monte Carlo dose engine of a commercial treatment planning system.
    Wagenaar D; Tran LT; Meijers A; Marmitt GG; Souris K; Bolst D; James B; Biasi G; Povoli M; Kok A; Traneus E; van Goethem MJ; Langendijk JA; Rosenfeld AB; Both S
    Phys Med Biol; 2020 Jan; 65(2):025006. PubMed ID: 31801119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Difference in LET-based biological doses between IMPT optimization techniques: Robust and PTV-based optimizations.
    Hirayama S; Matsuura T; Yasuda K; Takao S; Fujii T; Miyamoto N; Umegaki K; Shimizu S
    J Appl Clin Med Phys; 2020 Apr; 21(4):42-50. PubMed ID: 32150329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of grid size on uniform scanning and IMPT plans in XiO treatment planning system for brain cancer.
    Rana S; Zheng Y
    J Appl Clin Med Phys; 2015 Sep; 16(5):447–456. PubMed ID: 26699310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linear energy transfer distributions in the brainstem depending on tumour location in intensity-modulated proton therapy of paediatric cancer.
    Fjæra LF; Li Z; Ytre-Hauge KS; Muren LP; Indelicato DJ; Lassen-Ramshad Y; Engeseth GM; Brydøy M; Mairani A; Flampouri S; Dahl O; Stokkevåg CH
    Acta Oncol; 2017 Jun; 56(6):763-768. PubMed ID: 28423966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. End-of-Range Radiobiological Effect on Rib Fractures in Patients Receiving Proton Therapy for Breast Cancer.
    Wang CC; McNamara AL; Shin J; Schuemann J; Grassberger C; Taghian AG; Jimenez RB; MacDonald SM; Paganetti H
    Int J Radiat Oncol Biol Phys; 2020 Jul; 107(3):449-454. PubMed ID: 32240774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing biological effectiveness guided plan optimization strategies for cranial proton therapy: potential and challenges.
    Hahn C; Heuchel L; Ödén J; Traneus E; Wulff J; Plaude S; Timmermann B; Bäumer C; Lühr A
    Radiat Oncol; 2022 Oct; 17(1):169. PubMed ID: 36273132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dirty and clean dose concept: Towards creating proton therapy treatment plans with a photon-like dose response.
    Heuchel L; Hahn C; Ödén J; Traneus E; Wulff J; Timmermann B; Bäumer C; Lühr A
    Med Phys; 2024 Jan; 51(1):622-636. PubMed ID: 37877574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose averaged linear energy transfer optimization for large sacral chordomas in carbon ion therapy.
    Schafasand M; Resch AF; Nachankar A; Góra J; Martino G; Traneus E; Glimelius L; Georg D; Fossati P; Carlino A; Stock M
    Med Phys; 2024 Jun; 51(6):3950-3960. PubMed ID: 38696546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating Intensity Modulated Proton Therapy Relative to Passive Scattering Proton Therapy for Increased Vertebral Column Sparing in Craniospinal Irradiation in Growing Pediatric Patients.
    Giantsoudi D; Seco J; Eaton BR; Simeone FJ; Kooy H; Yock TI; Tarbell NJ; DeLaney TF; Adams J; Paganetti H; MacDonald SM
    Int J Radiat Oncol Biol Phys; 2017 May; 98(1):37-46. PubMed ID: 28587051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can differences in linear energy transfer and thus relative biological effectiveness compromise the dosimetric advantage of intensity-modulated proton therapy as compared to passively scattered proton therapy?
    Giantsoudi D; Adams J; MacDonald S; Paganetti H
    Acta Oncol; 2018 Sep; 57(9):1259-1264. PubMed ID: 29726722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inclusion of a variable RBE into proton and photon plan comparison for various fractionation schedules in prostate radiation therapy.
    Ödén J; Eriksson K; Toma-Dasu I
    Med Phys; 2017 Mar; 44(3):810-822. PubMed ID: 28107554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
    Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
    J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.